局部前列腺放疗与新发转移性前列腺癌的症状性局部事件
该回顾性、基于人群的队列研究纳入2005至2016年确诊的新发转移性前列腺癌患者1363例,其中46例(3.4%)接受局部前列腺放疗。局部前列腺放疗与更少的复发性泌尿生殖系统症状性局部事件相关(HR 0.34,95%CI 0.17-0.67,P=0.002),具体为上尿路梗阻和膀胱镜检查。
要点
- 局部前列腺放疗与更少的复发性泌尿生殖系统症状性局部事件相关(HR 0.34,95%CI 0.17-0.67)。
- 局部前列腺放疗与更少的上尿路梗阻相关(HR 0.20,95%CI 0.05-0.84)。
- 局部前列腺放疗与更少的膀胱镜检查相关(HR 0.38,95%CI 0.15-0.96)。
核心结论
- 在新发转移性前列腺癌中,局部前列腺放疗与更少的复发性泌尿生殖系统症状性局部事件相关,具体为上尿路梗阻和膀胱镜检查。
研究设计与样本
- 回顾性、基于人群的队列研究,纳入2005至2016年在癌症登记处初诊的新发转移性前列腺癌患者1363例,其中46例(3.4%)接受局部前列腺放疗。
- 局部前列腺放疗定义为诊断后1年内接受≥40 Gy放疗;转移负荷按STAMPEDE试验定义。
主要发现
- 局部前列腺放疗组与对照组的中位随访时间分别为28.9个月和27.3个月。
- 局部前列腺放疗与更少的复发性泌尿生殖系统症状性局部事件相关(HR 0.34,95%CI 0.17-0.67,P=0.002)。
- 局部前列腺放疗与更少的上尿路梗阻相关(HR 0.20,95%CI 0.05-0.84,P=0.03)。
- 局部前列腺放疗与更少的膀胱镜检查相关(HR 0.38,95%CI 0.15-0.96,P=0.04)。
- 转移负荷与症状性局部事件无显著关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Local prostate radiation therapy (LPRT) for low-burden metastatic prostate cancer (mPCa) improves overall survival and is the standard of care. The role of LPRT in reducing symptomatic local events (SLE) remains unclear. We aimed to identify SLE risk factors and to evaluate the association between LPRT and SLE in mPCa. METHODS AND MATERIALS: We conducted a retrospective, population-based cohort study of patients initially diagnosed with mPCa between 2005 and 2016 in a cancer registry. Patient, tumor, and treatment characteristics were obtained from chart review and the cancer registry. The coprimary endpoints were genitourinary (GU) and gastrointestinal (GI) SLE, identified by physician billing claims between 2004 and 2017 for diagnostic or therapeutic procedures potentially related to GU and GI SLE. The effect of LPRT on SLE was evaluated using both recurrent event (Andersen-Gill model) and time-to-first-event sequential landmark analyses. Risk factors for SLE were assessed by multivariable Cox regression. LPRT was defined as ≥40 Gy within 1 year of diagnosis. Metastatic burden was defined per the STAMPEDE trial. RESULTS: Of 1363 patients, 46 (3.4%) received LPRT. Median follow-up was 27.3 and 28.9 months in the control and LPRT groups, respectively. LPRT was associated with less recurrent GU SLE (hazard ratio [HR], 0.34; 95% confidence interval [CI], 0.17-0.67; P = .002), upper tract obstruction (HR, 0.20; 95% CI, 0.05-0.84; P = .03), and cystoscopy (HR, 0.38; 95% CI, 0.15-0.96; P = .04). Metastatic burden was not associated with SLE. CONCLUSIONS: LPRT in mPCa was associated with less recurrent GU SLE, specifically for upper tract obstruction and cystoscopy.
引用
- Kwok JK, Martell K, Sia M, et al. Local Prostate Radiation Therapy and Symptomatic Local Events in De Novo Metastatic Prostate Cancer. Pract Radiat Oncol. 2022. PMID: 36064183. doi:10.1016/j.prro.2022.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。